All In Biotech

Drug Trial Radar · NCT02372461

Randomized Trial of Amoxicillin Versus Placebo for (Fast Breathing) Pneumonia

A Double Blind Community-based Randomized Trial of Amoxicillin Versus Placebo for Fast Breathing Pneumonia in Children Aged 2-59 Months in Karachi, Pakistan

Last checked: Nov 19, 2026Latest source record: Sep 16, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 4,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,000

Actual

Start

Nov 9, 2014

Primary completion

Nov 2017

Study completion Nov 2017

Sponsor

Lead sponsor
Aga Khan UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 26, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 2 months, up to 59 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The relative benefits and risks of antibiotic therapy in WHO defined fast breathing pneumonia in pre-school children in resource limited settings are controversial both at an individual and public health level. Most infections are viral or self-limiting and non-selective drug treatment has contributed to the global epidemic of antibiotic resistance. There is no high quality trial evidence in managing children with fast breathing in community settings and the WHO itself has called for evidence on which to update guidance. The investigators proposed non inferiority trial comparing standard antibiotic treatment with placebo in poor urban slum settings in South Asia to address this deficit.

Conditions

  • Pneumonia
  • Tachypnea

Interventions

  • PlaceboDrug

    This is an non inferiority trial, the intervention is a placebo

  • AmoxicillinDrug

    Amoxicillin Liquid

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cumulative Treatment failureTime frame: Day 0-3

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • PHC at Ibrahim Haidry Goth, Ali Akber Shah Colony, Rerhi Goth, Bhains Colony

    Karachi, Sindh, Pakistan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.